Critical

Acute infective purpura fulminans

Microvascular thrombosis · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A rapidly progressive dermal microvascular thrombosis with haemorrhagic skin necrosis complicating severe sepsis (classically meningococcal), driven by DIC and an acquired protein C deficiency, often with septic shock and limb-threatening ischaemia.

Red flags

  • Rapidly expanding purpura with central necrosis
  • Profound shock and DIC
  • Limb ischaemia / threatened digits
  • Falling fibrinogen and platelets
  • Adrenal haemorrhage features (Waterhouse-Friderichsen)

Assessment

Differential diagnosis

  • Infective purpura fulminans (meningococcal, pneumococcal, streptococcal)
  • Disseminated intravascular coagulation of other cause
  • Catastrophic antiphospholipid syndrome
  • Warfarin-induced skin necrosis
  • Vasculitis / calciphylaxis

Investigations

  • Blood cultures and meningococcal/pneumococcal PCR (antibiotics first)
  • Coagulation screen, fibrinogen, D-dimer (DIC)
  • Protein C/S levels (acquired deficiency)
  • FBC, film, U&E, LFTs, lactate
  • Assess limb perfusion and compartments

Management

  • Recognise rapidly spreading retiform purpura with necrosis in a septic, shocked patient
  • Give broad-spectrum IV antibiotics immediately (cover meningococcus/pneumococcus)
  • Resuscitate septic shock: fluids guided by responsiveness and early vasopressors to MAP ≥65
  • Treat DIC: FFP, cryoprecipitate/fibrinogen and platelets guided by bleeding and results
  • Consider protein C concentrate / fresh frozen plasma to replace natural anticoagulants
  • Consider therapeutic anticoagulation (heparin) in the thrombotic phase per haematology advice
  • Protect and monitor limbs for compartment syndrome and gangrene; involve surgery early
  • Engage haematology and critical care; source control as needed

Drugs & doses

Ceftriaxone — 2 g IV immediately (meningococcal/pneumococcal cover)
Fresh frozen plasma — 15 mL/kg IV (replaces clotting factors and protein C/S)
Cryoprecipitate / fibrinogen concentrate — to keep fibrinogen >1.5 g/L
Noradrenaline — 0.05-0.5 mcg/kg/min IV titrated to MAP ≥65 mmHg
Unfractionated heparin — low-dose IV infusion in the thrombotic phase, per haematology (balance against bleeding)

Disposition

Critical care admission with haematology and surgical/plastics input; manage DIC, shock and limb viability in parallel.

Complications & pitfalls

  • Extensive skin necrosis requiring grafting
  • Peripheral gangrene and limb/digit amputation
  • Severe DIC with haemorrhage
  • Multi-organ failure
  • Death

Exam pearls

  • Purpura fulminans signals severe sepsis with DIC and acquired protein C deficiency — antibiotics cannot wait
  • Balance the thrombotic and bleeding phases of DIC with haematology guidance
  • Protein C replacement (via FFP or concentrate) targets the underlying deficiency
  • Early limb/compartment surveillance and surgical involvement reduce tissue loss

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.